Next Article in Journal
BTK Is the Target That Keeps on Giving: A Review of BTK-Degrader Drug Development, Clinical Data, and Future Directions in CLL
Next Article in Special Issue
Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies
Previous Article in Journal
Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma
Previous Article in Special Issue
The Functional Interaction Between Epstein–Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma
 
 
Communication

Article Versions Notes

Cancers 2025, 17(3), 556; https://doi.org/10.3390/cancers17030556
Action Date Notes Link
article pdf uploaded. 6 February 2025 15:26 CET Version of Record https://www.mdpi.com/2072-6694/17/3/556/pdf-vor
article supplementary file uploaded. 6 February 2025 15:26 CET - https://www.mdpi.com/2072-6694/17/3/556#supplementary
article xml file uploaded 8 February 2025 03:54 CET Original file -
article xml uploaded. 8 February 2025 03:54 CET Update https://www.mdpi.com/2072-6694/17/3/556/xml
article pdf uploaded. 8 February 2025 03:54 CET Updated version of record https://www.mdpi.com/2072-6694/17/3/556/pdf
article html file updated 8 February 2025 03:55 CET Original file https://www.mdpi.com/2072-6694/17/3/556/html
Back to TopTop